There are more than 130 Alzheimer’s drugs in development. Do a Google search for Alzheimer’s drugs in development.
I think a potential acquirer would be most interested in Anavex’s cash. I’m not saying the IP is worthless but Anavex’s technology is outside of the mainstream of scientific thought.